Cargando…
Tumor necrosis factor alpha and adalimumab differentially regulate CD36 expression in human monocytes
In chronic inflammatory diseases, such as rheumatoid arthritis, inflammation acts as an independent cardiovascular risk factor and the use of anti-inflammatory drugs, such as anti-tumor necrosis factor alpha (anti-TNFα), may decrease this risk. The phagocytosis of oxidized low density lipoproteins (...
Autores principales: | Boyer, Jean Frédéric, Balard, Patricia, Authier, Hélène, Faucon, Bruno, Bernad, José, Mazières, Bernard, Davignon, Jean-Luc, Cantagrel, Alain, Pipy, Bernard, Constantin, Arnaud |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1906797/ https://www.ncbi.nlm.nih.gov/pubmed/17335569 http://dx.doi.org/10.1186/ar2133 |
Ejemplares similares
-
Anti-TNF certolizumab pegol induces antioxidant response in human monocytes via reverse signaling
por: Boyer, Jean Frédéric, et al.
Publicado: (2016) -
Maintenance of cytomegalovirus-specific CD4(pos )T-cell response in rheumatoid arthritis patients receiving anti-tumor necrosis factor treatments
por: Davignon, Jean-Luc, et al.
Publicado: (2010) -
Modulation of T-cell responses by anti-tumor necrosis factor treatments in rheumatoid arthritis: a review
por: Davignon, Jean-Luc, et al.
Publicado: (2018) -
Cytomegalovirus infection: friend or foe in rheumatoid arthritis?
por: Davignon, Jean-Luc, et al.
Publicado: (2021) -
A new classification of HLA-DRB1 alleles differentiates predisposing and protective alleles for autoantibody production in rheumatoid arthritis
por: Gourraud, Pierre-Antoine, et al.
Publicado: (2007)